A 35-year-old man from rural India presents with a single, well-demarcated, hypopigmented patch with loss of sensation on his left arm. Slit-skin smear is negative. Which antileprotic drug regimen feature best distinguishes his likely diagnosis from lepromatous leprosy in terms of clofazimine use?

Explanation

## Clinical Case: Tuberculoid Leprosy — Clofazimine in MDT Regimens ### Case Analysis The patient presents with: - **Single lesion** with clear demarcation - **Loss of sensation** (neurological involvement) - **Negative slit-skin smear** (paucibacillary) - **Clinical diagnosis**: Tuberculoid leprosy (TT) ### MDT Regimens: Clofazimine as a Discriminator | Parameter | Tuberculoid Leprosy (TT) | Lepromatous Leprosy (LL) | |-----------|--------------------------|-------------------------| | **WHO MDT regimen** | Rifampicin + Dapsone (6 months) | Rifampicin + Dapsone + Clofazimine (12 months) | | **Clofazimine use** | NOT included | MANDATORY | | **Rationale** | Low bacillary load; two drugs sufficient | High bacillary load; three drugs needed | | **Borderline forms** | May use clofazimine if unstable | Always use clofazimine | **Key Point:** Clofazimine is a **hallmark of multibacillary (lepromatous) leprosy regimens**. Its presence or absence in the MDT is a key discriminator between paucibacillary (TT) and multibacillary (LL) forms. ### Why Clofazimine Is Used in LL but Not TT 1. **Bacterial burden**: LL has >10^6 bacilli; clofazimine's slow bacteriostatic action is essential for such high loads. 2. **Treatment duration**: LL requires 12 months; clofazimine accumulates in tissues and provides prolonged suppression. 3. **Relapse prevention**: In LL, the third drug reduces relapse from ~5% to <1%. 4. **TT efficacy**: Two drugs (rifampicin + dapsone) are sufficient in TT because: - Bacillary load is minimal (<100 bacilli) - Host immunity is strong and helps clear residual bacilli - Relapse rate is already <1% with two drugs **Mnemonic: "CLO-LL"** — Clofazimine is for **LL** (Lepromatous Leprosy). Tuberculoid leprosy does not need it. **High-Yield:** In NEET PG exams, when asked to distinguish TT from LL by drug regimen, the answer is almost always **clofazimine presence/absence**. TT = no clofazimine; LL = clofazimine mandatory. ### Clinical Pearl A patient with TT who is mistakenly given clofazimine will experience unnecessary side effects (skin discoloration, GI upset) without therapeutic benefit. Correct classification is essential for rational prescribing.